Literature DB >> 8685664

Clinical benefits of paid work activity in schizophrenia.

M D Bell1, P H Lysaker, R M Milstein.   

Abstract

Although indirect support can be found for the clinical benefits of work, it has not been studied in randomized designs, nor have critical variables been manipulated. One such variable is pay incentive. The authors present a study of 150 subjects with schizophrenia or schizoaffective disorder who were randomized into Pay ($3.40/hour) and No-Pay conditions and offered 6-month work placements within a Department of Veterans Affairs medical center. Subjects participated in a work-related support group and were evaluated weekly on symptom measures. Results indicated that Pay subjects worked more hours and earned more money than No-Pay subjects. Pay subjects showed more total symptom improvement at followup, and more improvement, particularly on positive and emotional discomfort symptoms. They also had a significant lower rate of rehospitalization than No-Pay subjects. Participation in work activity was closely associated with symptom improvement. Participators showed more total symptom improvement at followup than partial participators or nonparticipators, and more improvement, particularly on positive, hostility, and emotional discomfort symptoms. We concluded that pay increased participation and that, in this study, participation in work activity was primarily responsible for symptom reduction.

Entities:  

Mesh:

Year:  1996        PMID: 8685664     DOI: 10.1093/schbul/22.1.51

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  22 in total

Review 1.  Improving outcome in schizophrenia: the case for early intervention.

Authors:  A K Malla; R M Norman; L P Voruganti
Journal:  CMAJ       Date:  1999-03-23       Impact factor: 8.262

2.  Merging the fields of mental health and social enterprise: lessons from abroad and cumulative findings from research with homeless youths.

Authors:  Kristin M Ferguson
Journal:  Community Ment Health J       Date:  2011-10-02

3.  The Effectiveness of Supported Employment in People With Dual Disorders.

Authors:  Kim T Mueser; Kikuko Campbell; Robert E Drake
Journal:  J Dual Diagn       Date:  2011-05-11

4.  Work therapy for schizophrenic patients: results of a 3-year prospective study in Germany.

Authors:  T Reker; B Eikelmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

5.  The quality of work life of people with severe mental disorders working in social enterprises: a qualitative study.

Authors:  Nathalie Lanctôt; Marie-José Durand; Marc Corbière
Journal:  Qual Life Res       Date:  2011-11-16       Impact factor: 4.147

6.  Financial motivation to work among people with psychiatric disorders.

Authors:  Kristin L Serowik; Michael Rowe; Anne C Black; Karen Ablondi; Joanna Fiszdon; Charles Wilber; Marc I Rosen
Journal:  J Ment Health       Date:  2014-08

Review 7.  Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation.

Authors:  Susan R McGurk; Kim T Mueser; Thomas J DeRosa; Rosemarie Wolfe
Journal:  Schizophr Bull       Date:  2009-03-05       Impact factor: 9.306

8.  The impact of supported employment and working on clinical and social functioning: results of an international study of individual placement and support.

Authors:  Tom Burns; Jocelyn Catty; Sarah White; Thomas Becker; Marsha Koletsi; Angelo Fioritti; Wulf Rössler; Toma Tomov; Jooske van Busschbach; Durk Wiersma; Christoph Lauber
Journal:  Schizophr Bull       Date:  2008-04-09       Impact factor: 9.306

Review 9.  Interventions for obtaining and maintaining employment in adults with severe mental illness, a network meta-analysis.

Authors:  Yvonne B Suijkerbuijk; Frederieke G Schaafsma; Joost C van Mechelen; Anneli Ojajärvi; Marc Corbière; Johannes R Anema
Journal:  Cochrane Database Syst Rev       Date:  2017-09-12

10.  Impact of vocational rehabilitation on social functioning, cognitive functioning, and psychopathology in patients with chronic schizophrenia.

Authors:  P N Suresh Kumar
Journal:  Indian J Psychiatry       Date:  2008-10       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.